Quantcast

Latest Cholangiocarcinoma Stories

2011-07-21 14:10:36

Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the U.S. This population-based study publishing in the August issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, found that metabolic syndrome significantly increases risk of developing these primary liver cancers. According to data from the National Cancer Institute, 24,120 new cases of liver and intrahepatic bile duct cancer and close to...

2011-04-04 12:55:31

Scientists have confirmed that metabolic syndrome, a constellation of conditions that increases the risk of heart disease and diabetes, may also increase the risk of the two most common types of liver cancer, according to data presented at the AACR 102nd Annual Meeting 2011, held here April 2-6. Katherine McGlynn, Ph.D., a senior investigator at the National Cancer Institute, said approximately one-third of the U.S. population has metabolic syndrome, which is defined as the co-occurrence of...

2011-04-03 21:51:37

Well-known drug provides new hope for difficult to treat liver cancer patients Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma (HCC), according to data presented at the International Liver CongressTM 2011. A new study found thalidomide gave HCC patients who'd undergone grossly curative resection surgical removal of the cancerous part of the liver double the two-year disease free survival rate (65%) compared to placebo (33%). However, the...

2011-02-02 00:00:48

The Cholangiocarcinoma Foundation has designated February as cholangiocarcinoma awareness month. (PRWEB) February 1, 2011 The Cholangiocarcinoma Foundation has designated February as cholangiocarcinoma awareness month. Several events will be taking place this month in order to raise awareness of this rare cancer. Events include fundraising for 2011's Young Investigator Award, awareness drives on Facebook and Twitter and a call on Congress. "We wanted to designate a month where our...

2011-01-29 00:02:15

A recent study of 110 patients suffering from malignant pleural mesothelioma has found that although single modality therapy has traditionally been the most common treatment approach, it has largely failed to treat this aggressive cancer, leading to a continued poor prognosis. However, this study, led by Dr. Hesham A. El Hossieny, found that those patients who undergo a multimodal treatment regimen, including surgery, chemotherapy and radiation show the greatest results, especially when these...

2010-12-16 13:35:54

RFA highly valuable therapy for controlling cancerous nodules Researchers from Italy determined that radiofrequency ablation (RFA) is a safe and effective therapy for managing hepatocellular carcinoma (HCC) in cirrhotic patients. The high repeatability of RFA is advantageous in controlling recurrences of cancerous tumors in the liver. Results of this 10-year retrospective study are available in the January 2011 issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the...

2010-10-26 00:28:31

Treatment offers patients an alternative to surgery Adding chemotherapy to radiation therapy for muscle invasive bladder cancer allows 67 percent of people to be free of disease in their bladders two years after treatment. This compares to 54 percent of people who receive radiation alone, according to the largest randomized study of its kind presented at the plenary session, November 1, 2010, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO). "The trial shows...

2010-09-20 22:08:33

Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined. The most common strategies in the adjuvant treatment of gastric cancers include fluoropyrimidine-based chemotherapy with or without radiation. The introduction of capecitabine has largely replaced continuous-infusion 5-fluorouracil (5-FU)...

2010-09-08 13:46:41

Use of gemcitabine, a drug that can be effective in treating advanced and resected pancreatic cancer, did not result in improved overall survival after pancreatic cancer resection (surgical removal) compared to patients who received fluorouracil and folinic acid, another treatment regimen that has shown effectiveness, according to a study in the September 8 issue of JAMA. "Pancreatic cancer is one of the major causes of cancer death globally, with a 5-year survival rate of less than 5...


Latest Cholangiocarcinoma Reference Libraries

Chinese Liver Fluke, Clonorchis sinensis
2014-01-12 00:00:00

The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...

More Articles (1 articles) »
Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.